This reporting protocol is intended for reporting national case-based data for surveillance of hepatitis of unknown origin from all the countries and areas of the WHO European Region, including the 27 countries of the European Union (EU) and the additional three countries of the European Economic Area (EEA), to the European level.
New SARS-CoV-2 variants of interest and concern have continued to emerge in the first few months of 2022 and monitoring their circulation in all countries through genomic surveillance remains important.
Anthrax continues to be uncommon in humans in Europe, with only a few cases reported every year. For 2019, one confirmed anthrax case was reported by Hungary. Twenty-nine EU/EEA countries notified zero confirmed cases.
Anthrax continues to be uncommon in humans in Europe, with only a few cases reported every year. For 2020, three confirmed anthrax cases were reported by Italy. Twenty-eight EU/EEA countries notified zero confirmed cases.
This document provides technical guidance to laboratories, microbiology experts and relevant stakeholders in making decisions on establishing or scaling up capability and capacity to isolate and antigenically characterise circulating SARS-CoV-2 variants, and in making decisions on which methods to use.
In the context of the refugees fleeing the war in Ukraine, ECDC, UNHCR, UNICEF and WHO published a document which highlights key considerations for on-site assessment of refugee transit points and accommodation centres in the EU/EEA countries.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 29 May-4 June 2022 and includes updates on West Nile virus infection, COVID-19, Influenza, people displaced from Ukraine, hepatitis, Ebola, monkeypox, cholera, chikungunya and dengue.